{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 AST-Gram Negative Cefazolin (\u22641 - \u226532 \u00b5g/mL)"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K222073",
    "Predicate Device Reference 510(k) Number(s)": [
        "K213931"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "July 12, 2022",
    "Summary Letter Received Date": "July 14, 2022",
    "Submission Date": "June 24, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Cefazolin"
    ],
    "Specimen Type(s)": [
        "Gram negative bacilli",
        "Aerobic Gram-negative bacilli"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2",
        "VITEK\u00ae 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated quantitative antimicrobial susceptibility test",
        "Microdilution minimum inhibitory concentration (MIC) technique"
    ],
    "Methodologies": [
        "Automated antimicrobial susceptibility testing",
        "Microdilution"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Card",
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 AST-Gram Negative Cefazolin antimicrobial susceptibility testing reagent for use with VITEK\u00ae 2 and VITEK\u00ae 2 Compact systems",
    "Indications for Use Summary": "Designed for antimicrobial susceptibility testing of Gram negative bacilli with VITEK\u00ae 2 and VITEK\u00ae 2 Compact systems as a laboratory aid in determining in vitro susceptibility to cefazolin.",
    "fda_folder": "Microbiology"
}